• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CASHEL TRAPEASE PVCF FEM/JUG 55CM CSI; CATHETER, INTRAVASCULAR, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CASHEL TRAPEASE PVCF FEM/JUG 55CM CSI; CATHETER, INTRAVASCULAR, DIAGNOSTIC Back to Search Results
Catalog Number 466P306AU
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Vessel Or Plaque, Device Embedded In (1204); Pulmonary Embolism (1498); Pain (1994); Anxiety (2328)
Event Date 02/01/2017
Event Type  Injury  
Manufacturer Narrative
Additional information is pending and will be submitted within 30 days of this report.
 
Event Description
As reported in the legal brief, the patient underwent placement of a trapease vena cava (ivc) filter.The following additional information received per the patient profile form (ppf) indicates the device was implanted due to a history of morbid obesity with deep vein thrombosis (dvt) involving both legs that was unresponsive to medication.The patient is reported to have experienced pulmonary embolism and dvt subsequent to filter placement, the device is embedded the vessel, pain in the upper left leg and is reported to continue to experience anxiety related to the device.The patient is reported to have tolerated the index procedure without incident.
 
Manufacturer Narrative
As reported, the patient underwent placement of a trapease inferior vena cava (ivc) filter.The following additional information received per the patient profile form (ppf) indicates the device was implanted due to a history of morbid obesity with deep vein thrombosis (dvt) involving both legs that was unresponsive to medication.The patient is reported to have tolerated the index procedure without incident.The patient is reported to have experienced pulmonary embolism (pe) and dvt (deep vein thrombosis) subsequent to filter placement, the device is embedded the vessel, pain in the upper left leg and is reported to continue to experience anxiety related to the device.The filter remains implanted; thus, unavailable for analysis.The product was not returned for analysis and the sterile lot number has not been provided; therefore, no device analysis nor device history record review could be performed.The trapease vena cava filter is indicated for use in the prevention of recurrent pulmonary embolism (pe) via percutaneous placement in the vena cava for patients in which anticoagulants are contraindicated, anticoagulant therapy for thromboembolic disease has failed, emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced or for chronic, recurrent pulmonary embolism where anticoagulant therapy has failed, or is contraindicated.The purpose of a vena cava filter is to catch thrombus from the lower extremities as it travels along normal blood flow patterns up towards the heart.The predominant concern for embedding with in the wall of the ivc is the development of endothelialization.Endothelialization is the healing of the inner surfaces of vessels or grafts by endothelial cells.This is the normal process whereby the body heals and recovers from invasive procedures.Endothelialization has been shown to occur in as short a period as 12 days.Pe and dvt do not represent device malfunctions.Anxiety does not represent a device malfunction and may be related to underlying patient related issues.Clinical factors that may have influenced the event include patient, pharmacological and lesion characteristics.Without procedural films or images for review the reported event(s) could not be confirmed.Given the limited information available for review at this time, there is nothing to suggest that the reported events are related to the design and manufacturing process of the device; therefore, no corrective action will be taken.Should additional information become available, the file will be updated accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRAPEASE PVCF FEM/JUG 55CM CSI
Type of Device
CATHETER, INTRAVASCULAR, DIAGNOSTIC
Manufacturer (Section D)
CORDIS CASHEL
cahir road
cashel, co. tipperary
EI 
MDR Report Key7170821
MDR Text Key96583498
Report Number1016427-2018-00970
Device Sequence Number1
Product Code DQO
Combination Product (y/n)N
PMA/PMN Number
K020316
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 01/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number466P306AU
Device Lot Number19196332
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/08/2017
Initial Date FDA Received01/07/2018
Supplement Dates Manufacturer Received01/27/2018
Supplement Dates FDA Received01/30/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
UNKNOWN GILDEWIREUNKNOWN FILTER INTRODUCER
Patient Outcome(s) Life Threatening; Disability;
Patient Age43 YR
-
-